Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 3/20 | 0.53 |
| ▸ | PPARD | Q03181 | 2/20 | 0.49 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.47 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.47 |
| ▸ | NQO2 | P16083 | 1/20 | 0.47 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.46 |
| ▸ | ECE1 | P42892 | 5/20 | 0.46 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20214100 | 1.00 | PPARG (0.53) | PPARGPPARAPPARDMTNR1BSLC6A9 | |
| SCHEMBL820924 | 1.00 | PPARG (0.53) | PPARGPPARAPPARDMTNR1BSLC6A9 | |
| SCHEMBL820921 | 1.00 | PPARG (0.53) | PPARGPPARAPPARDMTNR1BSLC6A9 | |
| SCHEMBL6229546 | 1.00 | PPARG (0.53) | PPARGPPARAPPARDMTNR1BSLC6A9 | |
| SCHEMBL6207342 | 1.00 | PPARG (0.53) | PPARGPPARAPPARDMTNR1BSLC6A9 | |
| SCHEMBL821387 | 1.00 | PPARG (0.53) | PPARGPPARAPPARDMTNR1BSLC6A9 | |
| SCHEMBL13355771 | 0.89 | MTNR1A (0.48) | PPARGPPARAPPARDMTNR1BMTNR1A | |
| SCHEMBL820653 | 0.89 | MTNR1A (0.48) | PPARGPPARAPPARDMTNR1BMTNR1A | |
| SCHEMBL821467 | 0.89 | MTNR1A (0.48) | PPARGPPARAPPARDMTNR1BMTNR1A | |
| SCHEMBL1400250 | 0.84 | PPARA (0.62) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3548023-A1 | METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES | T3D Therapeutics, Inc. (US) | 2019-10-09 | — | — | EP | disclosed |
| WO-2018102358-A1 | METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES BASED ON APOE4 GENOTYPE | T3D THERAPEUTICS, INC. (US) | 2018-06-07 | — | — | WO | disclosed |
| WO-2018102399-A1 | METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES | T3D THERAPEUTICS, INC. (US) | 2018-06-07 | — | — | WO | disclosed |